• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liposomal sustained-release delivery systems for intravenous injection V. Biological disposition of liposome-entrapped lipophilic prodrug of 1-beta-D-arabinofuranosylcytosine.

作者信息

Tokunaga Y, Iwasa T, Fujisaki J, Sawai S, Kagayama A

出版信息

Chem Pharm Bull (Tokyo). 1988 Oct;36(10):4060-7. doi: 10.1248/cpb.36.4060.

DOI:10.1248/cpb.36.4060
PMID:3245983
Abstract
摘要

相似文献

1
Liposomal sustained-release delivery systems for intravenous injection V. Biological disposition of liposome-entrapped lipophilic prodrug of 1-beta-D-arabinofuranosylcytosine.
Chem Pharm Bull (Tokyo). 1988 Oct;36(10):4060-7. doi: 10.1248/cpb.36.4060.
2
Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-beta-D-arabinofuranosylcytosine prodrug-bearing liposomes.
Chem Pharm Bull (Tokyo). 1988 Sep;36(9):3574-83. doi: 10.1248/cpb.36.3574.
3
Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.用于静脉注射的脂质体缓释给药系统。II. 脂质体载体的设计及载有亲脂性丝裂霉素C前药的脂质体的血液处置
Chem Pharm Bull (Tokyo). 1988 Sep;36(9):3557-64. doi: 10.1248/cpb.36.3557.
4
Liposomal sustained-release delivery systems for intravenous injection. III. Antitumor activity of lipophilic mitomycin C prodrug-bearing liposomes.用于静脉注射的脂质体缓释给药系统。III. 载亲脂性丝裂霉素C前药脂质体的抗肿瘤活性。
Chem Pharm Bull (Tokyo). 1988 Sep;36(9):3565-73. doi: 10.1248/cpb.36.3565.
5
The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.用两种缓释形式的1-β-D-阿拉伯呋喃糖基胞嘧啶治疗静脉植入的Lewis肺癌。
Eur J Cancer Clin Oncol. 1984 Aug;20(8):1105-12. doi: 10.1016/0277-5379(84)90113-5.
6
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.隐形脂质体：一种用于1-β-D-阿拉伯呋喃糖基胞嘧啶的改进型缓释系统。
Cancer Res. 1992 May 1;52(9):2431-9.
7
Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.脂质体类型和给药途径在脂质体包裹的1-β-D-阿拉伯呋喃糖基胞嘧啶对小鼠L1210白血病抗肿瘤活性中的作用
Cancer Res. 1979 Apr;39(4):1390-5.
8
Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy.
Cancer Res. 1987 Aug 1;47(15):3935-7.
9
Distribution and metabolism of lipsome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues.
J Pharmacol Exp Ther. 1982 Aug;222(2):324-30.
10
Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.采用DepoFoam配制的药物药理学：一种使用多囊脂质体技术进行肠胃外给药的缓释药物递送系统。
Clin Pharmacokinet. 2006;45(12):1153-76. doi: 10.2165/00003088-200645120-00002.

引用本文的文献

1
Lipid-based drug carriers for prodrugs to enhance drug delivery.用于前药以增强药物递送的脂质基药物载体。
AAPS J. 2015 Jan;17(1):83-92. doi: 10.1208/s12248-014-9670-z. Epub 2014 Oct 1.
2
Clinical pharmacokinetics of cytarabine formulations.阿糖胞苷制剂的临床药代动力学。
Clin Pharmacokinet. 2002;41(10):705-18. doi: 10.2165/00003088-200241100-00002.
3
Liposomes as carriers of cancer chemotherapy. Current status and future prospects.脂质体作为癌症化疗的载体。现状与未来展望。
Drugs. 1993 Oct;46(4):618-38. doi: 10.2165/00003495-199346040-00004.